| Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process C Bennett, N Vakil, J Bergman, R Harrison, R Odze, M Vieth, S Sanders, ... Gastroenterology 143 (2), 336-346, 2012 | 480 | 2012 |
| Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study BJ Noordman, MCW Spaander, R Valkema, BPL Wijnhoven, ... The Lancet Oncology 19 (7), 965-974, 2018 | 255 | 2018 |
| BOB CAT: a large-scale review and Delphi consensus for management of Barrett’s esophagus with no dysplasia, indefinite for, or low-grade dysplasia C Bennett, P Moayyedi, DA Corley, J DeCaestecker, Y Falck-Ytter, G Falk, ... Official journal of the American College of Gastroenterology| ACG 110 (5 …, 2015 | 171 | 2015 |
| Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy KK Krishnadath, KK Wang, K Taniguchi, TJ Sebo, NS Buttar, ... Gastroenterology 119 (3), 624-630, 2000 | 164 | 2000 |
| Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett’s esophagus C Palles, L Chegwidden, X Li, JM Findlay, G Farnham, FC Giner, ... Gastroenterology 148 (2), 367-378, 2015 | 120 | 2015 |
| Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection F Peters, M Kara, W Rosmolen, M Aalders, F Ten Kate, K Krishnadath, ... Endoscopy 37 (05), 418-424, 2005 | 91 | 2005 |
| Accuracy of detecting residual disease after cross neoadjuvant chemoradiotherapy for esophageal cancer (preSANO Trial): rationale and protocol BJ Noordman, J Shapiro, MCW Spaander, KK Krishnadath, ... JMIR research protocols 4 (2), e4320, 2015 | 89 | 2015 |
| Nano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cell mediated immune response F Milano, L Mari, W van de Luijtgaarden, K Parikh, S Calpe, ... Frontiers in oncology 3, 137, 2013 | 70 | 2013 |
| Interphase in situ hybridization to disaggregated and intact tissue specimens of prostatic adenocarcinomas JC Alers, PJ Krijtenburg, KJ Vissers, SK Krishnadath, FT Bosman, ... Histochemistry and cell biology 104, 479-486, 1995 | 15 | 1995 |
| Radiotherapy combined with hyperthermia for primary malignant melanomas of the esophagus M Hulshof, PMA Van Haaren, PJ Zum Vörde Sive Vörding, S Krishnadath, ... Diseases of the Esophagus 23 (8), E42-E47, 2010 | 13 | 2010 |
| Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial BJ Wilk, BM Eyck, M Doukas, MCW Spaander, EJ Schoon, ... Journal of British Surgery 107 (13), 1791-1800, 2020 | 11 | 2020 |
| Detection of cytogenetic abnormalities by multi-color FISH in brush cytology specimens of Barrett's esophagus S Krishnadath, K Wang, K Halling, M Anderson, WG Liu, NS Buttar, ... Gastroenterology 122 (4), A289-A289, 2002 | 10 | 2002 |
| Endoscopic resection combined with photodynamic therapy for high grade dysplasia and early cancer in Barrett's esophagus F Peters, M Kara, W Rosmolen, F ten Kate, B Bultje, S Krishnadath, ... Gastrointestinal Endoscopy 59 (5), P251, 2004 | 9 | 2004 |
| Feasibility study of trastuzumab (T) and pertuzumab (P) added to neoadjuvant chemoradiotherapy (nCRT) in resectable HER2+ esophageal adenocarcinoma (EAC) patients (pts): The … S Schokker, RJ Molenaar, SL Meijer, RAA Mathot, S Van der Woude, ... Journal of Clinical Oncology 36 (15_suppl), 4057-4057, 2018 | 6 | 2018 |
| Genomic profiles of primary and metastatic esophageal adenocarcinoma identified via digital sorting of pure cell populations: results from a case report F Isidori, D Malvi, S Fittipaldi, C Forcato, I Bozzarelli, C Sala, G Raulli, ... BMC cancer 18, 1-6, 2018 | 4 | 2018 |
| Addendum: BOB CAT: a large-scale review and Delphi consensus for management of Barrett’s esophagus with no dysplasia, indefinite for, or low-grade dysplasia C Bennett, P Moayyedi, DA Corley, J DeCaestecker, Y Falck-Ytter, G Falk, ... Official journal of the American College of Gastroenterology| ACG 110 (6), 943, 2015 | 4 | 2015 |
| Medical and endoscopic management of high-grade dysplasia in Barrett’s esophagus KK Wang, JM Tian, E Gorospe, J Penfield, G Prasad, T Goddard, ... Diseases of the Esophagus 25 (4), 349-355, 2012 | 4 | 2012 |
| Barrett's Esophagus (BE) with High-Grade Dysplasia (HGD) and/or Early Cancer (EC): Stepwise Radical Endoscopic Resection (SRER) for Complete Removal of the BE Is Safe and Effective F Peters, M Kara, W Rosmolen, F ten Kate, S Krishnadath, J van Lanschot, ... Gastrointestinal Endoscopy 61 (5), AB140, 2005 | 4 | 2005 |
| Narrow Band Imaging (NBI) Elucidates the Surface Pattern Characteristics of High-Grade Intraepithelial Neoplasia (HGIN) in Barrett's Esophagus (BE) M Kara, F Peters, F ten Kate, K Krishnadath, P Fockens, J Bergman Gastrointestinal Endoscopy 61 (5), AB101, 2005 | 4 | 2005 |
| EAES Multidisciplinary Rapid Guideline: systematic review, meta-analysis, GRADE assessment and evidence-informed recommendations on the surgical management of paraesophageal … SR Markar, N Menon, N Guidozzi, KM Kontouli, D Mavridis, A Andreou, ... Surgical endoscopy 37 (12), 9013-9029, 2023 | 3 | 2023 |